Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 6, 1996, Pages 1352-1359

  Davidson, Michael G ^a   Lappin, Michael R ^a   Rottman, Jim R ^b   Tompkins, Mary B ^b   English, Robert V ^b   Bruce, Andrew T ^a   Jayawickrama, Judith ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; CLINDAMYCIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; AQUEOUS HUMOR; ARTICLE; CAT; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; EYE INFECTION; FEMALE; HEPATITIS; INTERSTITIAL PNEUMONIA; MALE; MORPHOMETRICS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0030068904     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.6.1352     Document Type: Article

References (62)

1. Adams, L. B., J. B. Hibbs, K. R. Taintor, and J. L. Krahenbauhl. 1990. Microbiostatic effect of murine activated macrophages for Toxoplasma gondii: role of synthesis of inorganic nitrogen oxides from L-arginine. J Immunol 144:2725-2729.
2. Araujo, F. G., and J. S. Remington. 1974 Effect of clindamycin on acute and chronic tovoplasmosis in mice. Antimicrob. Agents Chemother. 5:647-651.
3. Black, C. M., D. M. Israelski, Y. Suzuki, and J. S. Remington. 1989. Effect of recombinant tumor necrosis factor on acute infection in mice with Toxoplasma gondii or Trypanosoma cruzi. Immunology 68:570-574
4. Breitschwerdt, E. B., M. G. Davidson, D. P. Aucoin, M. G. Levy, N. S. Szabados, B. C. Hegarty, A. L. Kuehne, and R. L. James. 1991. Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs. Antimicrob Agents Chemother. 35:2375-2381.
5. Brown, S. A., T. M. Dieringer, R. P. Hunter, and M. J. Zaya. 1989. Oral clindamycin disposition after single and multiple doses in normal cats. J. Vet. Pharmacol. Ther. 12:209-216.
6. Brown, S. A., M. J. Zaya, T. M. Dieringer, R. P. Hunter, J. L. Nappier, G. A. Hoffman, R. E. Hornish, and F. S. Yein. 1990 Tissue concentration of clindamycin after multiple oral doses in normal cats. J. Vet Pharmacol. Ther. 13:270-277.
7. Chang, H. R., G. E. Grau, and J. C. Pechere. 1990. Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology 69:33-37.
8. Chavkin, M. J., M. R. Lappin, C. C. Powell, S. M. Roberts, C. J. Parshall, and J. S. Reif. 1992. Seroepidemiologic and clinical observations of 93 cases of uveitis in cats. Prog. Vet. Comp Ophthalmol. 2:29-36.
9. Dannemann, B. R., J. A. McCutchan, D. M. Israelski, D. Antoniskis, C. Osheport, P. N. C. Hesoltine, T. M. Leedom, N. Clumeck, P. Morlat, and J. S. Remington. 1991. Treatment of acute toxoplasmosis with intravenous clindamycin. Eur. J Clin. Microbiol. Infect. Dis. 19:193-195.
10. Davidson, M. G., and K. T. Baty. 1991. Anaphylaxis associated with intravenous sodium fluorescein administration in a cat. Prog. Vet. Comp. Ophthalmol. 1:127-128.
11. Davidson, M. G., M. R. Lappin, R. V. English, and M. B. Tompkins. 1993. A feline model of ocular toxoplasmosis Invest. Ophthalmol. Vis. Sci 34: 3653-3660.
12. Davidson, M. G., J. R. Rottman, R. V. English, M. R. Lappin, and M. B. Tompkins. 1993. Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am. J. Pathol. 143:1486-1497.
13. Derouin, F., J. Nalpas, and C. L. Chastang. 1988. In vitro assessment of macrolide, lincosamides, and synergestines on Toxoplasma gondii. Pathol. Biol. 36:1204-1220.
14. Dubey, J. P., and J. K. Frenkel. 1976. Feline toxoplasmosis from acutely infected mice and the development of Toxoplasma cysts. J Protozool. 23: 537-546.
15. Dubey, J. P., G. V. Swan, and J. K. Frenkel. 1972. A simplified method for isolation of Toxoplasma gondii from the feces of cats. J. Parasitol. 58:1005-1006.
16. Dubey, J. P., and R. A. Yeary. 1977. Anticoccidial activity of 2-sulfamoyl-4,4-diaminodiphenylsulfone, sulfadiazine, pyrimethamine and clindamycin in cats infected with Toxoplasma gondii. Can. Vet. J. 18:51-57.
17. Engstrom, R. E., G. N. Holland, R. B. Nussenblatt, and D. A. Jabs. 1991. Current practices in the management of ocular toxoplasmosis. Am. J. Ophthalmol. 111:601-610
18. Ferguson, J. G. 1981. Clindamycin therapy for toxoplasmosis. Ann. Ophthalmol. 13:95-100.
19. Filice, G. A., and C. Pomeroy. 1991. Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice. Antimicrob Agents Chemother. 35:780-782.
20. Follette, G. L., J. Gambertoglio, J. A. White, D. W. Knuth, and E. T. Lin. 1988. Determination of clindamycin by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 431:379-388.
21. Greene, C. E., M. R. Lappin, and A. Marks. 1992. Effect of clindamycin on clinical, hematological, and biochemical parameters in clinically healthy cats. J. Am. Anim. Hosp. Assoc. 28:323-326
22. Guldsten, H. 1983. Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis. Acta Ophthalmol. 61:51-57.
23. Hand, W. L., D. L. Hand, and N. L. King-Thompson. 1990. Antibiotic inhibition of respiratory burst response in human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 34:863-870.
24. Hand, W. L., and N. L. King-Thompson. 1986. Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity. Antimicrob. Agents Chemother. 29:135-140.
25. Hand, W. L., and N. L. King-Thompson. 1982. Membrane transport of clindamycin in alveolar macrophage. Antimicrob. Agents Chemother. 21: 241-247.
26. Harper, J. S., W. T. London, and J. L. Sever. 1985. Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys. Am. J. Trop. Med. Hyg. 34:50-57.
27. Harris, C., M. P. Salgo, H. B. Tanowitz, and M. Wittner. 1988. In vitro assessment of antimicrobial agents against Toxoplasma gondii. J. Infect. Dis. 157:14-22
28. Hirth, R. S., and S. W. Nielsen. 1969. Pathology of feline toxoplasmosis. J. Small Anim Pract. 10:213-221.
29. Hoffin, J. M., and J. S. Remington. 1987. Clindamycin in a murine model of toxoplasmic encephalitis. Antimicrob Agents Chemother. 31:492-496.
30. Israelski, D. M., and J. S. Remington. 1990 Activity of gamma interferon in combination with pyrimethamine or clindamycin it treatment of murine toxoplasmosis. Eur J. Clin. Microbiol. Infect. Dis. 9:358-360.
31. Jacobs, G., M. R. Lappin, A. Marks, and C. E. Greene. 1989 Effect of clindamycin on factor VII activity in healthy cats. Am. J. Vet. Res 50:393-395
32. Jacobson, M. A., C. L. Besch, C. Child, R. Hafner, K. Muth, D. N. Wentworth, and L. Deyton. 1992. Toxicity of clindamycin as prophylaxis for AIDS associated toxoplasmic encephalitis Lancet 339:333-334.
33. Johnson, J. D., W. L. Hand, J. B. Francis, N. King-Thompson, and R. W. Corwin. 1980. Antibiotic uptake by alveolar macrophage. J. Lab. Clin. Med. 95:429-439.
34. Johnson, T. A., and D. W. Wichern. 1988. Applied multivariate statistical analysis, 2nd ed., p. 607. Prentice-Hall, Inc., Englewood Cliffs, N.J.
35. Lakhanpal, V., S. S. Schocket, and V. S. Nirankari. 1983. Clindamycin in the treatment of toxoplasmic retinochoroiditis. Am. J. Ophthalmol. 95:605-613.
36. Lappin, M. R., S. Cayatte, C. C. Powell, A. Gigliotti, C. Cooper, and S. M. Roberts. 1993. Detection of Toxoplasma gondii-antigen containing immune complexes in the serum of cats. Am. J. Vet. Res. 54:415-419.
37. Lappin, M. R., C. E. Greene, S. Winston, S. L. Toll, and M. E. Epstein. 1989 Clinical feline toxoplasmosis: serologic and therapeutic management of 15 cases. J. Vet. Intern. Med. 3:139-143.
38. Lappin, M. R., S. M. Roberts, M. G. Davidson, C. L. Powell, and J. S. Reif. 1992. Enzyme-linked immunosorbent assays for the detection of Toxoplasma gondii-specific antibodies and antigens in the aqueous humor of cats. J. Am. Vet Med Assoc 201:1010-1016.
39. Leport, C., G. S. Bastuji, C. Perronne, D. Salmon, C. Marche, F. Bricaire, and J. L. Vilde, 1989. An open study of pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis. J. Infect. Dis. 160:557-558.
40. Levy, R. M., D. E. Bredesen, and M. L. Rosenblum. 1985. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J. Neurosurg. 62:475-495.
41. Mack, D. G., and R. McLeod. 1984. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A. Antimicrob. Agents Chemother. 26:26-30.
42. McMaster, P. R. B., K. G. Powers, J. F. Finerty, and M. N. Lunde. 1973 The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice Am. J. Trop Med. Hyg. 22:14-17.
43. Noess, A., B. Hauge, and C. O. Solberg. 1989. Effects of clindamycin and cefuroxime on leukocyte membrane receptors and function. Chemotherapy (Basel) 35:193-199.
44. Parker, G. A., J. M. Langloss, J. P. Dubey, and E. H. Hoover. 1981. Pathogenesis of acute toxoplasmosis in specific-pathogen-free cats. Vet. Pathol. 18:786-803
45. Pedrol, E., J. M. Gonzolez-Clemente, J. M. Gattel, J. Mallolas, J. M. Miro, F. Graus, R. Alvarez, J. M. Mercader, J. Berenguer, M. T. Jimenez de Anta, M. E. Valls, and E. Soriano. 1990. Central nervous system toxoplasmosis in AIDS patients: efficacy of intermittent maintenance therapy AIDS 4:511-517.
46. Pfefferkorn, E. R., R. F. Nothnagel, and S. E. Borotz. 1992. Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant. Antimicrob. Agents Chemother 36: 1091-1096
47. Piketty, C., F. Derouin, B. Rouveix, and J. J. Pocidalo. 1990. In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice. Antimicrob Agents Chemother. 34:1467-1472.
48. Remington, J. S., and J. L. Vilde. 1991. Clindamycin for toxoplasma encephalitis in AIDS. Lancet 338:1142-1143.
49. Rothova, A., C. Meenken, H. J. Buitenhuis, C. J. Brinkman, G. S. Baarsma, T. N. Boen-Tan, P. T. V. M. deJong, N. Klaassen-Broekema, C. M. C. Schweitzer, Z. Timmerman, J. de Vries, M. J. W. Zaal, and A, Kijlstra. 1993. Therapy of ocular toxoplasmosis Am J. Ophthalmol. 115:517-523.
50. Ruf, B., and H. D. Pohle. 1991. Role of clindamycin in the treatment of acute Loxoplasmosis of the central nervous system. Eur J Clin. Microbiol. Infect. Dis. 10:183-186
51. Sharma, S. D., J. R. Catterall, and J. S. Remington. 1986 Parasiticidal activity of macrophage against Toxoplasma Methods Enzymol. 132:626-637
52. Sibley, L. D., L. B. Adams, Y. Fukutomi, and J. L. Krahenbuhl. 1991. Tumor necrosis factor alpha triggers antitoxoplasmal activity in gamma interferon primed macrophage J Immunol 147:2350-2355.
53. Sibley, L. D., L. B. Adams, and J. L. Krahenbuhl. 1993. Macrophage interactions in toxoplasmosis. Forum Immunol 48:38-40.
54. Smith, R. E. 1990 Toxoplasmic retinochoroiditis as an emerging problem in AIDS patients. Am. J. Ophthalmol. 106:738-739.
55. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240:516-518.
56. Tabbara, K. F. 1986. Ocular toxoplasmosis In K F Tabbara and R. A. Hynkiuk (ed). Infections of the eye Little, Brown & Co . Toronto
57. Tabbara, K. F., J. Dy-Liacco, R. A. Nozik, G. R. O'Connor, and H. J. Blackman. 1979. Clindamycin in chronic toxoplasmosis Effect of periocular injection on recoverability of organisms from healed lesions in the rabbit eye. Arch. Ophthalmol. 97:542-544.
58. Tabbara, K. F., R. A. Nozik, and G. R. O'Connor. 1974. Clindamycin effects on experimental ocular toxoplasmosis in the rabbit. Arch. Ophthalmol. 92: 244-247.
59. Tabbara, K. F., and G. R. O'Connor. 1980 Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine. Ophthalmology 87:129-134.
60. Theirmann, E., W. Apt, A. Atias, M. Lorca, and J. Olguin. 1983. A comparative study of some combined treatment regimens in acute toxoplasmosis in mice. Am. J. Trop Med Hyg 27:747-750
61. Tolstonn, K. V. I. 1991 Treatment of acute toxoplasmosis with oral clindamycin. Eur. J. Clin. Miciobiol Infect. Dis. 10:181-183.
62. Tompkins, M. B., and R. V. English. Unpublished data